KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

TherapeuticsMD (TXMD) Operating Margin: 2010-2024

Historic Operating Margin for TherapeuticsMD (TXMD) over the last 15 years, with Dec 2024 value amounting to 270.30%.

  • TherapeuticsMD's Operating Margin rose 9736.00% to 109.95% in Q3 2025 from the same period last year, while for Sep 2025 it was 61.80%, marking a year-over-year increase of 35649.00%. This contributed to the annual value of 270.30% for FY2024, which is 38431.00% up from last year.
  • Per TherapeuticsMD's latest filing, its Operating Margin stood at 270.30% for FY2024, which was up 58.71% from 654.61% recorded in FY2023.
  • Over the past 5 years, TherapeuticsMD's Operating Margin peaked at 1.70% during FY2022, and registered a low of 3,092.77% during FY2021.
  • Moreover, its 3-year median value for Operating Margin was 270.30% (2024), whereas its average is 307.74%.
  • As far as peak fluctuations go, TherapeuticsMD's Operating Margin plummeted by 285,301bps in 2021, and later soared by 309,447bps in 2022.
  • MRY analysis of 5 years shows TherapeuticsMD's Operating Margin stood at 239.77% in 2020, then tumbled by 1,190bps to 3,092.77% in 2021, then soared by 100bps to 1.70% in 2022, then tumbled by 38,554bps to 654.61% in 2023, then surged by 59bps to 270.30% in 2024.
  • Its Operating Margin stands at 270.30% for FY2024, versus 654.61% for FY2023 and 1.70% for FY2022.